Payer Matrix

Payer Matrix’s Precision Medication Compatibility (Pharmacogenomics) program leverages the science of genetic testing to help providers select medications that are safer and more effective for each individual. Only those genes that affect how the body processes medications are tested, with a simple and painless buccal (cheek) swab. Making sure members are on the right medications and dosages for their individual drug metabolism profile can prevent adverse events, reduce trial-and-error prescribing, and lower healthcare costs - potentially saving thousands per member per year.

We offer a PEPM model, and use claims data to identify those members who are most likely to benefit. Population analysis allows us to give ROI projections on how much the Plan could benefit from implementing a PGx-informed Comprehensive Medication Management Program. Our dedicated clinical team coordinates with members and providers to ensure appropriate implementation of any pharmacist-recommended medication adjustments, with the white-glove service we are known for. Management continues with ongoing review of claims data to identify new candidates, alerts when new medications with PGx guidance are prescribed, and retrospective analysis. All testing is performed by CLIA-licensed laboratories.